Definition: binds specifically to antibody or TCR. Immunogen: antigen that can ALSO trigger immune response by itself. All immunogens = antigens, not all antigens = immunogens.
Immunogenicity factors:
Epitope (antigenic determinant): specific small region recognized by Ab/TCR. One antigen = multiple epitopes. B cell epitope: surface, conformational (3D dependent). T cell epitope: linear peptide (processed, unfolded).
Hapten: small, antigenic but NOT immunogenic alone. Needs carrier (protein) coupling → hapten-carrier complex → immunogenic. Examples: penicillin allergy, nickel dermatitis (drug/metal + host protein).
By origin: Exogenous (outside → endocytic pathway → MHC-II) vs Endogenous (inside host cell — viral/tumor protein → cytosolic pathway → MHC-I).
By chemical nature: Protein, Polysaccharide, Lipid, Nucleic acid.
By T-cell dependence:
By relation to host:
Other: Superantigens (microbial, e.g. staph toxins — bypass processing, bridge TCR Vβ directly to MHC-II, massive nonspecific T cell activation). Tumor antigens — see Transplant/Tumor Immunology topic.
Structure: Y-shaped, 4 chains — 2 heavy + 2 light, disulfide-linked. Variable region (N-terminus, antigen-binding, differs per Ab) + Constant region (conserved within class).
Fab (fragment antigen-binding): Y arms, light chain + heavy chain V+C1 domains. ANTIGEN BINDING. Fc (fragment crystallizable): Y stem, heavy chain constant regions. EFFECTOR FUNCTIONS (complement, Fc receptor binding).
Light chains: Kappa or Lambda — ONE type per antibody molecule, never mixed. Heavy chains: γ, μ, α, δ, ε — DEFINES the Ig class.
| Class | Heavy chain | Structure | Key feature |
|---|---|---|---|
| IgG | γ | Monomer | Most abundant (~75%). ONLY class crosses placenta. Secondary/memory response. Opsonization, complement, ADCC. |
| IgM | μ | Pentamer | FIRST Ab in primary response. LARGEST Ig. Best complement activator (pentamer = high avidity). Stays intravascular. |
| IgA | α | Monomer(serum)/Dimer(secretory) | Dominant in mucosal secretions (saliva, tears, colostrum, gut, respiratory). Secretory form has secretory component. First-line mucosal defense. |
| IgD | δ | Monomer | Mainly membrane-bound naive B cell receptor. Minimal serum function. B cell activation/tolerance role. |
| IgE | ε | Monomer | LOWEST serum concentration. Binds mast cell/basophil high-affinity FcR. Type I hypersensitivity. Anti-helminthic immunity. |
Primary (1st exposure): lag before Ab detected. IgM first, modest IgG rise. Low titer, short-lived. Secondary/Memory (re-exposure): memory B cells respond fast. IgG dominates from start (prior class switch). Higher, faster, LONGER-persisting titer.
= basis of vaccination/booster dosing.
An antigen is any substance capable of binding specifically to an antibody or a T-cell receptor. A subset of antigens — immunogens — can additionally trigger an immune response on their own; every immunogen is an antigen, but not every antigen is capable of inducing a response by itself.
Immunogenicity depends on several properties working together. Foreignness matters most — the immune system is built around distinguishing self from non-self, so the degree of an antigen’s difference from the host’s own molecules broadly predicts how strong a response it provokes. Molecular size matters too: large molecules (typically >10 kDa) are generally more immunogenic than small ones, since a larger surface offers more distinct sites for recognition. Chemical complexity — proteins (the most immunogenic class) and polysaccharides are generally strong immunogens; lipids and nucleic acids are weak on their own, becoming immunogenic mainly when carried on a protein or polysaccharide backbone. Physical form also plays a role — particulate and aggregated antigens tend to be more immunogenic than soluble ones, since particulate material is phagocytosed more readily.
Susceptibility to processing is a genuine requirement, not a minor detail: an antigen must be able to be degraded and presented on an MHC molecule for a T-cell-dependent response to occur at all — a property that separates thymus-dependent antigens (needing this processing) from thymus-independent antigens (which can activate B cells directly, without it).
An epitope (antigenic determinant) is the specific, small region of an antigen actually recognized by an antibody or T cell receptor — a single large antigen typically carries multiple distinct epitopes, each capable of provoking its own antibody response. B cell epitopes are usually surface-exposed and conformational (dependent on the molecule’s 3D folding); T cell epitopes are linear peptide sequences, since T cells only recognize antigen after it has been processed and unfolded.
A hapten is a small molecule that is antigenic (can bind antibody) but not immunogenic on its own (cannot provoke an antibody response by itself) — it becomes immunogenic only once it is chemically coupled to a larger carrier molecule (typically a protein), which supplies the additional epitopes needed for full T-cell-dependent activation. This is exactly the mechanism behind several clinically important reactions: penicillin allergy and nickel contact dermatitis both arise because the small hapten (the drug or metal) binds host protein to form a hapten-carrier complex that the immune system then treats as foreign.
Antigens are classified along several axes depending on what’s clinically useful to distinguish:
An antibody (immunoglobulin, Ig) is a glycoprotein produced by plasma cells that binds a specific antigen. The basic unit is a Y-shaped molecule of four polypeptide chains — two identical heavy chains and two identical light chains — held together by disulfide bonds. Each chain has a variable region (at the N-terminus, differing between antibodies, forming the actual antigen-binding site) and a constant region (largely conserved within a class).
Functionally, the molecule splits into two fragments: Fab (fragment antigen-binding) — the two arms of the Y, each containing one light chain plus the variable and first constant domains of a heavy chain, responsible for actual antigen binding; and Fc (fragment crystallizable) — the stem of the Y, made of the constant regions of both heavy chains, responsible for the antibody’s effector functions (complement fixation, binding to Fc receptors on phagocytes and other effector cells).
Light chains come in two types, kappa and lambda, and any single antibody molecule carries only one type or the other, never a mix. Heavy chains come in five types — γ, μ, α, δ, ε — and it is the heavy chain type that actually defines an antibody’s class.
| Class | Heavy chain | Structure | Key features |
|---|---|---|---|
| IgG | γ | Monomer | Most abundant serum Ig (~75%); only class crossing the placenta; secondary/memory response; opsonization, complement activation, ADCC |
| IgM | μ | Pentamer | First antibody made in a primary response; largest Ig; efficient complement activator (its pentameric structure gives it high avidity); stays intravascular (too large to cross into tissue) |
| IgA | α | Monomer (serum) / Dimer (secretory) | Dominant in mucosal secretions (saliva, tears, colostrum, gut, respiratory tract); secretory form carries a protective secretory component; first-line mucosal defence |
| IgD | δ | Monomer | Mainly a membrane-bound B cell receptor on naive B cells; minimal serum function; role in B cell activation and tolerance |
| IgE | ε | Monomer | Lowest serum concentration; binds high-affinity Fc receptors on mast cells/basophils; mediates type I hypersensitivity; also involved in anti-helminthic immunity |
Antibodies protect the host through several distinct mechanisms working together: neutralization (physically blocking a toxin or virus from binding its target receptor); opsonization (coating a pathogen so phagocytes, which carry Fc receptors, engulf it more efficiently); complement activation (the classical pathway is triggered specifically by antigen-bound IgM or IgG, leading to the membrane attack complex and target lysis); agglutination (clumping particulate antigens, such as whole bacteria or red cells, together); precipitation (clumping soluble antigens out of solution); and ADCC (directing nonspecific cytotoxic cells to an antibody-tagged target via Fc receptor engagement).
On first antigen exposure (primary response), there is a lag before detectable antibody appears, IgM predominates initially with a modest IgG rise following, and overall antibody titre is low and short-lived. On re-exposure to the same antigen (secondary/memory response), memory B cells generated during the primary response respond rapidly, IgG dominates from the start (thanks to prior class switching), and the antibody titre rises higher, faster, and persists longer — the entire practical basis of vaccination and booster dosing.
Personal revision notes, mnemonics and reminders.
